139 related articles for article (PubMed ID: 24515936)
21. A Simple Infection Control Protocol Durably Reduces External Ventricular Drain Infections to Near-Zero Levels.
Flint AC; Toossi S; Chan SL; Rao VA; Sheridan W
World Neurosurg; 2017 Mar; 99():518-523. PubMed ID: 28012890
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a self-fulfilling hypothesis: chlorhexidine dressing for reduction of microbial colonization of the skin with central venous catheters.
Schierholz JM; Beuth J; Pulverer G
J Hosp Infect; 2000 Mar; 44(3):241-3. PubMed ID: 10706809
[No Abstract] [Full Text] [Related]
23. Randomized Controlled Trial to Reduce Bacterial Colonization of Surgical Drains with the Use of Chlorhexidine-Coated Dressings After Breast Cancer Surgery.
Rivera-Buendía F; Franco-Cendejas R; Román-López CG; Colín-Castro CA; Becerra-Lobato N; García-Hernández ML; Cornejo-Juárez P; Bargalló-Rocha JE; Medina-Franco H; Vilar-Compte D
Ann Surg Oncol; 2019 Nov; 26(12):3883-3891. PubMed ID: 31346895
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
Timsit JF; Mimoz O; Mourvillier B; Souweine B; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Lepape A; Vesin A; Arrault X; Schwebel C; Adrie C; Zahar JR; Ruckly S; Tournegros C; Lucet JC
Am J Respir Crit Care Med; 2012 Dec; 186(12):1272-8. PubMed ID: 23043083
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
[TBL] [Abstract][Full Text] [Related]
26. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
[TBL] [Abstract][Full Text] [Related]
27. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin.
Bashir MH; Olson LK; Walters SA
Am J Infect Control; 2012 May; 40(4):344-8. PubMed ID: 21737178
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activity of a novel adhesive containing chlorhexidine gluconate (CHG) against the resident microflora in human volunteers.
Carty N; Wibaux A; Ward C; Paulson DS; Johnson P
J Antimicrob Chemother; 2014 Aug; 69(8):2224-9. PubMed ID: 24722839
[TBL] [Abstract][Full Text] [Related]
29. No infection reduction using chlorhexidine wipes in total joint arthroplasty.
Farber NJ; Chen AF; Bartsch SM; Feigel JL; Klatt BA
Clin Orthop Relat Res; 2013 Oct; 471(10):3120-5. PubMed ID: 23504539
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis.
O'Horo JC; Silva GL; Munoz-Price LS; Safdar N
Infect Control Hosp Epidemiol; 2012 Mar; 33(3):257-67. PubMed ID: 22314063
[TBL] [Abstract][Full Text] [Related]
31. Chlorhexidine use in the neonatal intensive care unit: results from a national survey.
Tamma PD; Aucott SW; Milstone AM
Infect Control Hosp Epidemiol; 2010 Aug; 31(8):846-9. PubMed ID: 20586654
[TBL] [Abstract][Full Text] [Related]
32. Safety of Biweekly Chlorhexidine Gluconate Bathing in Infants 36 To 48 Weeks' Postmenstrual Age.
Chandonnet CJ; Toole C; Young V; Feldman HA; Kellogg M; Kim J; Scoville M; Porter C; Weekes M; Wild S; DeGrazia M
Am J Crit Care; 2019 Nov; 28(6):451-459. PubMed ID: 31676520
[TBL] [Abstract][Full Text] [Related]
33. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
Maunoury F; Motrunich A; Palka-Santini M; Bernatchez SF; Ruckly S; Timsit JF
PLoS One; 2015; 10(6):e0130439. PubMed ID: 26086783
[TBL] [Abstract][Full Text] [Related]
35. Culture-independent detection of chlorhexidine resistance genes qacA/B and smr in bacterial DNA recovered from body sites treated with chlorhexidine-containing dressings.
Choudhury MA; Sidjabat HE; Rathnayake IU; Gavin N; Chan RJ; Marsh N; Banu S; Huygens F; Paterson DL; Rickard CM; McMillan DJ
J Med Microbiol; 2017 Apr; 66(4):447-453. PubMed ID: 28463667
[TBL] [Abstract][Full Text] [Related]
36. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing.
Scheithauer S; Lewalter K; Schröder J; Koch A; Häfner H; Krizanovic V; Nowicki K; Hilgers RD; Lemmen SW
Infection; 2014 Feb; 42(1):155-9. PubMed ID: 23934685
[TBL] [Abstract][Full Text] [Related]
37. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
Crawford AG; Fuhr JP; Rao B
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
[TBL] [Abstract][Full Text] [Related]
38. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.
Frost SA; Hou YC; Lombardo L; Metcalfe L; Lynch JM; Hunt L; Alexandrou E; Brennan K; Sanchez D; Aneman A; Christensen M
BMC Infect Dis; 2018 Dec; 18(1):679. PubMed ID: 30567493
[TBL] [Abstract][Full Text] [Related]
40. Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit.
Popovich KJ; Hota B; Hayes R; Weinstein RA; Hayden MK
Intensive Care Med; 2010 May; 36(5):854-8. PubMed ID: 20213074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
